BioNTech (ADR) (BNTX)
Develops oncology medicines while commercializing the Pfizer-partnered Comirnaty vaccine.
$100.87
After hours+0.07 (+0.07%)
At close$100.80(+2.86%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 42 days
EPS estimate
$0.85
Revenue estimate
$1.21B
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$1.15−$1.82−$1.82−$0.14−$1.44−$2.43−$3.70Pending
Estimate$0.46−$2.48−$2.69−$1.12−$0.22−$2.54−$2.40$0.85
Surprise+148.7%+26.5%+32.3%+87.5%−556.7%+4.4%−54.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$1.23B$200.4M$307.1M$1.78B$1.07B$136.4M$120.6MPending
Estimate$1.18B$215.1M$177.8M$843.7M$902.3M$207.4M$180.2M$1.21B
Surprise+4.4%−6.8%+72.7%+110.9%+18.1%−34.2%−33.1%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.41 | — | — |
| Sep 2027 | −$0.14 | — | — |
| Jun 2027 | −$3.40 | — | — |
| Mar 2027 | −$3.22 | — | — |
| Dec 2026 | −$1.41 | — | — |
| Nov 2026 | $0.85 | — | — |
| Aug 2026 | −$2.40 | −$3.70 | −54.3% |
| May 2026 | −$2.54 | −$2.43 | +4.4% |
| Mar 2026 | −$0.22 | −$1.44 | −556.7% |
| Nov 2025 | −$1.12 | −$0.14 | +87.5% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Dec 2019 | |||
| Nov 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.41 | — | — | $180.0M | — | — | — |
| Sep 2027 | −$0.14 | — | — | $834.5M | — | — | — |
| Jun 2027 | −$3.40 | — | — | $132.0M | — | — | — |
| Mar 2027 | −$3.22 | — | — | $153.5M | — | — | — |
| Dec 2026 | −$1.41 | — | — | $508.5M | — | — | — |
| Nov 3, 2026 | $0.85 | — | — | $1.21B | — | — | — |
| Aug 4, 2026 | −$2.40 | −$3.70 | −54.3% | $180.2M | $120.6M | −33.1% | −1.0% |
| May 5, 2026 | −$2.54 | −$2.43 | +4.4% | $207.4M | $136.4M | −34.2% | −3.9% |
| Mar 10, 2026 | −$0.22 | −$1.44 | −556.7% | $902.3M | $1.07B | +18.1% | −17.9% |
| Nov 3, 2025 | −$1.12 | −$0.14 | +87.5% | $843.7M | $1.78B | +110.9% | +0.1% |
| Aug 4, 2025 | |||||||
| May 5, 2025 | |||||||
| Mar 10, 2025 | |||||||
| Nov 4, 2024 | |||||||
| Aug 5, 2024 | |||||||
| May 6, 2024 | |||||||
| Mar 20, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 8, 2023 | |||||||
| Mar 27, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 9, 2022 | |||||||
| Mar 30, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 30, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 11, 2020 | |||||||
| May 12, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Nov 14, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |